Doctrine page

Publication of Applications

When does a patent application become open to the public in India?

Under section 11A, ordinarily, an application for patent shall not be open to public before the expiry of 18 months, but the applicant may make a request in Form 9.

Doctrine last updated on 7 October 2026

Cite this page

Publication of Applications, Ali on Patents, www.aop.onl/publication

1Ordinarily, an application for patent shall not be open to public before the expiry of 18 months from the date of filing of application or the date of priority of the application whichever is earlier. (Patents Act 1970, s 11A(1); Patents Rules 2003, r 24.) The applicant may make a request in Form 9, upon the payment of prescribed fee, for an early publication before the expiry of the 18-month period mentioned in s 11A(1) of the Patents Act. (Ibid, s 11A(2); Ibid, r 24A.) Every application shall be published within one month from the date of expiry of the 18 month period or one month from the date of request for publication under r 24A, except applications in respect of which there are secrecy directions or applications which are abandoned under s 9 or applications which are withdrawn three months before the expiry of 18 months. (Ibid, s 11A(3).) In the case of applications in respect of which secrecy directions have been given under s 35, such applications shall be published after the expiry of 18 months or when the secrecy directions has ceased to operate, whichever is later. (Ibid, s 11A(4).)

2Every application published under s 11A shall include particulars with regard to the date of the application, number of the application, name and address of the applicant identifying the application and an abstract. (Ibid, s 11A(5).) In the case of an application for an invention involving biological material, upon the publication of such application, the depository institution will make the biological material available to the public. (Ibid, s 11A(6)(a).) The Patent Office may make the application together with the complete and provisional specification, drawings and abstract available to the public on payment of the prescribed fees. (Ibid, s 11A(6)(b); Patents Rules 2003, r 27.) A request may be made in writing on payment of the prescribed fees and copies of the said documents may be procured from the appropriate office.

3Section 11A(7) of the Patents Act pertains to rights of an applicant. The said provision was introduced to accommodate the transitory hurdles that usually accompany a regime change. Prior to 1 January 2005, the Patents Act went through a 10-year transition period during which the patent office began to receive applications for product patents for pharmaceuticals and agro-chemicals. As the rights in a patent accrue retrospectively, there was a real possibility of the right holders proceeding against the competitors who were using the subject matter of invention prior to 1 January 2005. Section 11A(7) protects the rights of competitors and provides for reasonable royalty to the right holder.

4The section provides that the applicant shall have like rights and privileges from the date of publication of the application for the patent till the date of grant of a patent, as if a patent for the invention had been granted on the date of publication of the application. However, s 11A(7) imposes the following restrictions:

(1) the applicant shall not be entitled to institute any proceedings for infringement until the patent has been granted;

(2) the rights of a patentee in respect of applications made under s 5(2) before 1 January 2005 shall accrue from the date of grant of the patent; (Section 5 was omitted by the Patents (Amendment) Act 2005 with retrospective effect from 1 January 2005.)

(3) after a patent is granted in respect of applications made under s 5(2), the patent-holder shall only be entitled to receive reasonable royalty from such enterprises which have made significant investment and were producing and marketing the concerned product prior to 1 January 2005 and which continue to manufacture the product covered by the patent on the date of grant of the patent and no infringement proceedings shall be instituted against such enterprises.

5The third restriction detailed above is likely to come under judicial scrutiny for many reasons. First, it restricts the right to institute a suit for infringement against an alleged infringer and confines the remedy to receiving royalty. Secondly, the clause does not give any guidance as to the authority that would determine the royalty and what amount would be reasonable. Ordinarily, it is the Controller who determines the royalty in the case of compulsory licences. Though the courts have evolved detailed guidelines for the award of royalty in the case of licences, it remains to be seen whether the same principles would apply to compute the royalty paid under s 11A(7). Thirdly, the clause requires the enterprise (competitor) to produce and market the concerned product prior to 1 January 2005. This requirement may impose difficulties if the enterprise did not, on its own, market the concerned product. Fourthly, the requirement that the enterprise should ‘continue to manufacture’ the concerned product may cause problems where the enterprise is restrained by the right-holder by some other means, such as a temporary injunction procured pursuant to the grant of exclusive marketing rights under the Patents Act.

Provisions and topics

Provisions
Topics

See also

Doctrine page

Rights Between Publication and Grant

What are the rights of an applicant between the publication of the application and grant of patent?

Doctrine page

Request for Examination

How does a patent application get examined in India?

Doctrine page · Written by Prof. Feroz Ali

www.aop.onl/publication